Skip to content

Clinical trials

Observational alpha 1-Antitrypsin Deficiency trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: alpha 1-Antitrypsin Deficiency Phase: Observational Country / region: United States Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20073
20081
20134
20152
20162
20182
20191
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting6
Active, not recruiting2
Terminated2
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Florida4
Columbia University3
Medical University of South Carolina3
National Heart, Lung, and Blood Institute (NHLBI)3
Alpha-1 Foundation2
Arbor Research Collaborative for Health2
Adverum Biotechnologies, Inc.1
Biocerna LLC1
Coram Clinical Trials1
National Center for Research Resources (NCRR)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
alpha 1-Antitrypsin Deficiency25
Pulmonary Disease, Chronic Obstructive6
Genetic Diseases, Inborn5
Emphysema4
Alagille Syndrome2
Cholestasis2
Cystic Fibrosis2
Fibrosis2
Liver Cirrhosis2
Lung Diseases2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.